248 results
Page 4 of 13
8-K
EX-99.1
jwlt78xywk2n
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
k919lw ksv73a1amyho
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
k6ehu4
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-99.1
s3e9ozgrgshmzujyfuk
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
p2i39o3xck5 evc5
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-2.1
cqbky1gwn
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
w4fav1iroms
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
EX-99.1
gxs0nb9 do
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
pu3 14v45rnjzo1xqm7
8 Dec 21
Regulation FD Disclosure
6:55am
8-K/A
EX-99.1
gn7qx77
16 Nov 21
Results of Operations and Financial Condition
6:30am
8-K
EX-99.2
f1iz44og 03991ej
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.3
12aeugsi2z 5wscv
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.1
k92ud
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
SC TO-I
EX-99
3e7l10zk668nk
26 Aug 21
Issuer tender offer statement
4:55pm
8-K
EX-99.1
ybcedtzy
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-99.1
oipfre5m c48na3o
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am